Summary
Medulloblastoma, the most common malignancy of childhood, was originally shown to be sensitive to cyclophosphamide in 1981. We have used combined laboratory and clinical investigations to demonstrate the synergy of cyclophosphamide and vincristine in the treatment of this tumor, the therapeutic gain associated with escalation of the dosage of cyclophosphamide, the consequence of and mechanisms underlying resistance of medulloblastoma to cyclophosphamide, the emerging importance of the neuroaxis as a site of relapse of medulloblastoma, and newer approaches, including intrathecal 4-hydroperoxycyclophosphamide and busulfan, to treat neuraxis disease. These studies serve as a paradigm for laboratory-clinical translational research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ, Bigner DD: Medulloblastoma: Tumor biological and clinical perspectives. J Neurooncol 11: 1–15, 1991
Allen JC, Helson L: High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J Neurosurg 55: 749–756, 1981
Friedman HS, Bigner SH, McComb RD, Schold SC Jr, Pasternak JF, Groothuis DR, Bigner DD: A model for human medulloblastoma: Growth, morphology, and chromosomal analysisin vitro and in athymic mice. J Neuropathol Exp Neurol 42: 485–503, 1983
Friedman HS, Burger PC, Bigner SH, Trojanowski JW, Wikstrand CJ, Halperin EC, Bigner DD: Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 44: 592–605, 1985
Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Brodeur GM, He X, Wikstrand CJ, Kurtzberg J, Berens ME, Halperin EC, Bigner DD: Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc. Am J Pathol 130: 472–484, 1988a
Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD: Amplification of the c-myc gene in medulloblastoma cell lines and xenografts. Cancer Res 50: 2347–2350, 1990
Friedman HS, Colvin OM, Ludeman SM, Schold SC Jr, Boyd VL, Mulhbaier LH, Bigner DD: Experimental chemotherapy of human medulloblastoma with classical alkylators. Cancer Res 46: 2827–2833, 1986a
Friedman HS, Colvin OM, Shapek SX, Ludeman SM, Elion GB, Schold SC Jr, Jacobsen PF, Muhlbaier LH, Bigner DD: Experimental chemotherapy of human medulloblastoma cell lines and transplantable xenografts with bifunctional alkylating agents. Cancer Res 48: 4189–4195, 1988b
Friedman HS, Mahaley MS Jr, Schold SC Jr, Vick NA, Falletta JM, Bullard DE, D'Souza BJ, Khandekar JD, Lew S, Oakes WJ, Bigner DD: Efficacy of vincristine and cyclo-phosphamide in the therapy of recurrent medulloblastoma. Neurosurgery 18: 335–340, 1986b
Duffner PK, Horowitz ME, Krischer J, Friedman HS, Burger PC, Cohen ME, Sanford R, Mulhern RK, Scidel FG, Kun L: Postoperative chemotherapy and delayed radiation in children less than 3 years of age with malignant brain tumors: A pediatric oncology group study. New Engl J Med 328: 1725–1731, 1993
Mosijczuk AD, Nigro MA, Thomas PRM, Burger PC, Krischer JP, Morantz R, Mulne AF, Towbin RB, Freeman AI, Kurdunowiez B, Nigro ED, Friedman HS, Kun LE: Pre radiation chemotherapy in advanced medulloblastoma: A Pediatrie Oncology Group pilot study. Cancer 72: 2755–2762.
Lachance DH, Oette D, Schold SC Jr, Brown M, Kurtzberg J, Graham ML, Tien R, Felsberg G, Colvin OM, Moghrabi A, Browning I, Hockenberger B, Stewart E, Ferrell L, Kerby T, Duncan-Brown M, Golembe B, Fuchs H, Fredericks R, Hayes FA, Rubin AS, Bigner DD, Friedman HS: Dose escalation trial of cyclophosphamide with sargramostim in the treatment of central nervous system (CNS) neoplasms. Med Pediatr Oncol 24: 241–247, 1995
Moghrabi A, Fuchs H, Brown M, Schold SC Jr, Graham M, Kurtzberg J, Tien R, Felsberg G, Lachance DH, Colvin OM, Oette D, Hockenberger B, Stewart E, Ferrell L, Kerby T, Duncan-Brown M, Bigner DD. Friedman HS: Cyclophos-phamide in combination with sargramostim for treatment of recurrent medulloblastoma. Med Pediatr Oncol, in press, 1994
Friedman HS, Schold SC Jr, Mahaley MS, Colvin OM, Oakes WJ, Vick NA, Burger PC, Bigner SH, Borowitz M, Halperin EC, Djang W, Falletta JM, DeLong R, Garvin JH, DeVivo DC, Norris D, Golumbe B, Winter J, Bodziner RA, Sipahi H, Bigner DD: Phase II treatment of medulloblastoma and pineoblastoma with melphalan: Clinical therapy based on experimental models of human medulloblastoma. J Clin Oncol 7: 904–911, 1989
Mahoney D, Strother D, Bowen T, Ghim T, Pick T, Wall D, Yu L, Friedman HS: High dose melphalan (MELP) and cyclophosphamide (CTX) with autologous bone marrow rescue (ABMR) for recurrent/progressive malignant brain tumors (BT) in children: A phase I–II pediatric oncology group study (abstract). Proc Am Soc Clin Oncol 13: 174, 1994
Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW: Cyclophosphamide resistance in medulloblastoma. Cancer Res 52: 5373–5378, 1992
Friedman HS, Colvin OM, Aisaka K, Popp J, Bossen EH, Reimer KA, Powell JB, Hilton J, Gross SS, Levi R, Bigner DD, Griffith OW: Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity. Cancer Res 50: 2455–2462, 1990
Colvin M, Chabner BA: Alkylator agents. In: Chabner BA, Collins JM (eds) Cancer Chemotherapy: Principles and Practice. JP Lippincott, Philadelphia, 1990, pp 276–313
Aaron RH, Elion GB, Colvin OM, Graham M, Keir S, Bigner DD, Friedman HS: Busulfan therapy of central nervous system xenografts in athymic mice. Cancer Chemother Pharmacol 35: 127–131, 1994
Fuchs HE, Archer GE, Colvin OM, Bigner SH, Schuster JM, Fuller GN, Schold SC Jr, Muhlbaier LH, Friedman HS, Bigner DD: Activity of intrathecal 4-hydroperoxycyclo-phosphamide in a nude rat model of human neoplastic meningitis. Cancer Res 50: 1954–1959, 1990
Friedman HS, Ochs J, Finlay J, Geyer R, Arndt C, Cohen B, Phillips P, Strauss LC, Hochberg F, Schold SC, Bigner DD, Colvin OM: Phase I trial of intrathecal 4-hydroperoxycyclo-phosphamide for neoplastic meningitis (abstract). Proc Am Assoc Cancer Res 34: 269, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Friedman, H.S., Bigner, S.H. & Bigner, D.D. Cyclosphosphamide therapy of medulloblastoma: From the laboratory to the clinic and back again (and again and again). J Neuro-Oncol 24, 103–108 (1995). https://doi.org/10.1007/BF01052667
Issue Date:
DOI: https://doi.org/10.1007/BF01052667